rs142793481

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001374353.1(GLI2):​c.720C>T​(p.Asp240Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00629 in 1,613,764 control chromosomes in the GnomAD database, including 54 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0050 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0064 ( 53 hom. )

Consequence

GLI2
NM_001374353.1 synonymous

Scores

1
2
11

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.885

Publications

2 publications found
Variant links:
Genes affected
GLI2 (HGNC:4318): (GLI family zinc finger 2) This gene encodes a protein which belongs to the C2H2-type zinc finger protein subclass of the Gli family. Members of this subclass are characterized as transcription factors which bind DNA through zinc finger motifs. These motifs contain conserved H-C links. Gli family zinc finger proteins are mediators of Sonic hedgehog (Shh) signaling and they are implicated as potent oncogenes in the embryonal carcinoma cell. The protein encoded by this gene localizes to the cytoplasm and activates patched Drosophila homolog (PTCH) gene expression. It is also thought to play a role during embryogenesis. The encoded protein is associated with several phenotypes- Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome, preaxial polydactyly type IV, postaxial polydactyly types A1 and B. [provided by RefSeq, Jul 2008]
GLI2 Gene-Disease associations (from GenCC):
  • holoprosencephaly 9
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Illumina, Ambry Genetics
  • combined pituitary hormone deficiencies, genetic form
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • holoprosencephaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0040371716).
BP6
Variant 2-120968790-C-T is Benign according to our data. Variant chr2-120968790-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 259735.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.885 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00497 (757/152372) while in subpopulation SAS AF = 0.00745 (36/4830). AF 95% confidence interval is 0.00553. There are 1 homozygotes in GnomAd4. There are 462 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 53 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GLI2NM_001374353.1 linkc.720C>T p.Asp240Asp synonymous_variant Exon 6 of 14 ENST00000361492.9 NP_001361282.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GLI2ENST00000361492.9 linkc.720C>T p.Asp240Asp synonymous_variant Exon 6 of 14 1 NM_001374353.1 ENSP00000354586.5

Frequencies

GnomAD3 genomes
AF:
0.00497
AC:
757
AN:
152254
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00125
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00360
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.00270
Gnomad SAS
AF:
0.00765
Gnomad FIN
AF:
0.0233
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00498
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00729
AC:
1833
AN:
251292
AF XY:
0.00737
show subpopulations
Gnomad AFR exome
AF:
0.000801
Gnomad AMR exome
AF:
0.0107
Gnomad ASJ exome
AF:
0.000496
Gnomad EAS exome
AF:
0.00245
Gnomad FIN exome
AF:
0.0214
Gnomad NFE exome
AF:
0.00575
Gnomad OTH exome
AF:
0.00865
GnomAD4 exome
AF:
0.00643
AC:
9391
AN:
1461392
Hom.:
53
Cov.:
34
AF XY:
0.00643
AC XY:
4674
AN XY:
727046
show subpopulations
African (AFR)
AF:
0.000687
AC:
23
AN:
33480
American (AMR)
AF:
0.00957
AC:
428
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000689
AC:
18
AN:
26134
East Asian (EAS)
AF:
0.00224
AC:
89
AN:
39700
South Asian (SAS)
AF:
0.00843
AC:
727
AN:
86250
European-Finnish (FIN)
AF:
0.0210
AC:
1113
AN:
53100
Middle Eastern (MID)
AF:
0.0106
AC:
61
AN:
5768
European-Non Finnish (NFE)
AF:
0.00589
AC:
6549
AN:
1111850
Other (OTH)
AF:
0.00634
AC:
383
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
551
1102
1654
2205
2756
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
252
504
756
1008
1260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00497
AC:
757
AN:
152372
Hom.:
1
Cov.:
33
AF XY:
0.00620
AC XY:
462
AN XY:
74498
show subpopulations
African (AFR)
AF:
0.00125
AC:
52
AN:
41594
American (AMR)
AF:
0.00359
AC:
55
AN:
15314
Ashkenazi Jewish (ASJ)
AF:
0.000864
AC:
3
AN:
3472
East Asian (EAS)
AF:
0.00290
AC:
15
AN:
5176
South Asian (SAS)
AF:
0.00745
AC:
36
AN:
4830
European-Finnish (FIN)
AF:
0.0233
AC:
248
AN:
10622
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00498
AC:
339
AN:
68044
Other (OTH)
AF:
0.00284
AC:
6
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
41
81
122
162
203
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00509
Hom.:
2
Bravo
AF:
0.00368
TwinsUK
AF:
0.00431
AC:
16
ALSPAC
AF:
0.00623
AC:
24
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.00547
AC:
47
ExAC
AF:
0.00731
AC:
888
Asia WGS
AF:
0.00318
AC:
11
AN:
3478
EpiCase
AF:
0.00523
EpiControl
AF:
0.00456

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 17, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

GLI2: BP4, BP7, BS2 -

Mar 14, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria. -

Jan 20, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Holoprosencephaly 9;C4014479:Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome Benign:1
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Holoprosencephaly 9 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.19
CADD
Benign
3.2
DANN
Uncertain
0.99
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.064
N
LIST_S2
Benign
0.40
T
MetaRNN
Benign
0.0040
T
MetaSVM
Benign
-0.99
T
PhyloP100
-0.89
PROVEAN
Benign
-1.6
N
REVEL
Benign
0.16
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.049
D
MVP
0.40
ClinPred
0.023
T
GERP RS
-4.8
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142793481; hg19: chr2-121726366; COSMIC: COSV58047232; API